share_log

Iterum Therapeutics Q4 Adj EPS $(0.81) Beats $(0.93) Estimate

Moomoo 24/7 ·  Mar 28 08:50

Iterum Therapeutics (NASDAQ:ITRM) reported quarterly losses of $(0.81) per share which beat the analyst consensus estimate of $(0.93) by 12.9 percent. This is a 55.77 percent decrease over losses of $(0.52) per share from the same period last year.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment